TRAVIS LLOYD: Open Payments
NPI 1881214336 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,558 in 95 payments from 18 companies in 2025. Trend: 2023 $1,633 · 2024 $1,393 · 2025 $1,558
Food & beverage: $1,558
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $343 |
| Novo Nordisk Inc | 23 | $327 |
| Amgen Inc. | 12 | $179 |
| Lilly USA, LLC | 5 | $100 |
| ABBVIE INC. | 5 | $88 |
| Janssen Pharmaceuticals, Inc | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Corcept Therapeutics | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: CAPLYTA, Wegovy, OTEZLA, Ozempic, SPRAVATO, TRINTELLIX, Auvelity, MOUNJARO.
Industry payments across GA — which companies pay providers there.
